Natera Inc (NTRA)
Natera Inc (NTRA) carries a ŷRobot AI score of 56 out of 100. The model's fair value estimate is $427.81, 5.7% above the last close of $404.79. The chart signal reads Sell.
| Metric | NTRA |
|---|---|
| AI score | 56 / 100 |
| Chart signal | Sell |
| Fair value estimate | $427.81 |
| Upside to fair value | 5.7% |
| Previous close | $404.79 |
| P/E | -298.15 |
| Price / sales | 21.75 |
| Market cap | $56.65B |
| EPS | -1.37 |
| Revenue growth | 34.4% |
| 1-year price change | 34.5% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about NTRA
Is NTRA overvalued or undervalued right now?
As of Oct 15, 2026, ŷRobot's fair-value model estimates Natera Inc (NTRA) at $427.81 against a last close of $404.79, implying 5.7% upside to the model's estimate.
Is NTRA's chart signal bullish or bearish?
The chart-signal model classifies NTRA as Neutral as of Oct 15, 2026, with a signal score of -0.13 on a -1 to 1 scale.
What is NTRA's ŷRobot AI score?
NTRA scores 56 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 15, 2026.
Is NTRA stock expensive on P/E and P/S?
NTRA trades at -298.2 times earnings and 21.7 times sales as of Oct 15, 2026.
What does NTRA's seasonal forecast show?
ŷRobot's seasonal forecast curve for NTRA reads -0.6% at 30 days, -1.8% at 90 days, and +34.5% at one year as of Oct 15, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is NTRA growing?
Natera Inc's revenue growth is +34.4% and free-cash-flow growth is +12.9% on the latest reported figures.
NTRA chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.